← Eichor
Study identifier: NCT07605806 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions

Condition: Healthy Volunteer · Hypersensitivity Reactions · Vancomycin  ·  Sponsor: Johns Hopkins University

PhasePhase 1/Phase 2
Planned participants25
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The goal of this clinical trial is to investigate biomarkers of non-IgE-mediated immediate hypersensitivity reactions during infusion of intravenous vancomycin. The main question it aims to answer is: • Identifying novel biomarkers in blood that occur during infusion reaction Participants will: * Have allergy skin testing for vancomycin * Receive an infusion of vancomycin

This description comes directly from the study's public registry record.

Talk to the study team

Jennifer Hoffmann  ·  4109551318  ·  jhoffm45@jh.edu

Pooja Akoijam  ·  410-955-1201  ·  pakoija1@jh.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Johns Hopkins University School of MedicineBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07605806